Combination therapy and nanotechnology offer a promising therapeutic method in cancer
treatment. By improving drug's pharmacokinetics, nanoparticulate systems increase the …

Based on exceptional advantages of aptamers, increasing attention has been presented in
the utilise of them as targeted ligands for cancer drug delivery. Recently, the progress of …

Breast cancer is one of the leading causes of mortality among women worldwide due to
aggressive behavior, early metastasis, resistance to existing chemotherapeutic agent and …

Targeted drug delivery systems using nanocarriers offer a versatile platform for breast
cancer treatment; however, a robust, CD44-targeted niosomal formulation has not been …

Combination chemotherapy has become a treatment modality for breast cancer. However,
serious side effects and high cytotoxicity associated with this combination therapy make it a …

Abstract Development of the acquired resistance is one major obstacle during
chemotherapy for cancer patients. Exosomes mediate intercellular communication and …

In this study, a folic acid-functionalized niosome was formulated and loaded with letrozole
and curcumin as a promising drug carrier system for chemotherapy of the breast cancer …

Lung cancer is the second most prevalent and first killer cancer worldwide, and conventional
approaches do not have enough ability to suppress it. Therefore, a novel targeted chitosan …

The main adverse effect of doxorubicin is cardiotoxicity. Oxidative stress and apoptosis
induction have been suggested as mechanisms involved in its cardiotoxicity. In this study …

Abstract MiR-142-3p has been reported to act as a tumor suppressor in breast cancer.
However, the regulatory effect of miR-142-3p on drug resistance of breast cancer cells and …